scholarly article | Q13442814 |
P356 | DOI | 10.1186/S12879-017-2259-2 |
P8608 | Fatcat ID | release_7zawi3evm5gotmfah46vkrwlyq |
P932 | PMC publication ID | 5319166 |
P698 | PubMed publication ID | 28219322 |
P50 | author | Andrea Teng | Q57902327 |
Nick Wilson | Q90100179 | ||
Tony Blakely | Q57449785 | ||
Nisha Nair | Q91141347 | ||
Giorgi Kvizhinadze | Q91141350 | ||
Melissa McLeod | Q91141353 | ||
P2860 | cites work | Illustrating Economic Evaluation of Diagnostic Technologies: Comparing Helicobacter pylori Screening Strategies in Prevention of Gastric Cancer in Canada | Q59404619 |
Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer | Q77932028 | ||
Comparison of a stool antigen test and serology for the diagnosis of Helicobacter pylori infection in mass survey | Q83504231 | ||
Helicobacter pylori eradication for the prevention of gastric neoplasia | Q24186365 | ||
Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection | Q24632307 | ||
Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection | Q28214073 | ||
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. | Q30485861 | ||
The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial | Q30677538 | ||
Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials | Q33636554 | ||
Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups | Q33792622 | ||
The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model | Q35112530 | ||
A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial | Q36339226 | ||
Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results | Q37003878 | ||
Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection | Q37605214 | ||
Increasing primary antibiotic resistance and ethnic differences in eradication rates of Helicobacter pylori infection in New Zealand--a new look at an old enemy | Q38155771 | ||
The fight against gastric cancer - the IARC Working Group report | Q38273500 | ||
The contribution of Helicobacter pylori to excess gastric cancer in Indigenous and Pacific men: a birth cohort estimate | Q40448559 | ||
Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials | Q41018165 | ||
Trends in Helicobacter pylori infection among Māori, Pacific, and European Birth cohorts in New Zealand | Q41658285 | ||
Helicobacter pylori test-and-treat program can be cost-effective to prevent gastric cancer in Taiwanese adults: referred to the nationwide reimbursement database | Q41670325 | ||
Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of H. pylori? | Q41675055 | ||
Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese | Q43777110 | ||
Global burden of gastric cancer attributable to Helicobacter pylori | Q44946941 | ||
Social inequalities or inequities in cancer incidence? Repeated census-cancer cohort studies, New Zealand 1981-1986 to 2001-2004 | Q49109423 | ||
Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer. | Q51101883 | ||
Whom should we "test and treat" for Helicobacter pylori? | Q52839621 | ||
P433 | issue | 1 | |
P921 | main subject | Helicobacter pylori | Q180556 |
Helicobacter pylori infectious disease | Q4497153 | ||
P304 | page(s) | 156 | |
P577 | publication date | 2017-02-20 | |
P1433 | published in | BMC Infectious Diseases | Q15759919 |
P1476 | title | A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity | |
P478 | volume | 17 |
Search more.